Skopos Labs, Inc. Arcturus Therapeutics Holdings Inc. Transaction History
Skopos Labs, Inc.
- $497 Million
- Q2 2025
A detailed history of Skopos Labs, Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 37 shares of ARCT stock, worth $550. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37
Previous 37
-0.0%
Holding current value
$550
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARCT
# of Institutions
162Shares Held
25.7MCall Options Held
312KPut Options Held
96.5K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$69.9 Million0.11% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$39.5 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.83MShares$27.3 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.1.83MShares$27.3 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$27 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $396M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...